Ditching the word psychedelic is helping employers embrace therapies that show "groundbreaking results" including faster recovery and more productive employees, explains Sherry Rais, CEO and co-founder of Enthea, in this episode. In addition to health improvements, these therapies can lead to lower healthcare costs and lower disability costs. Hear more about psychedelic-assisted therapies that can be effective with treatment-resistant patients, studies underway in this episode of the DMEC podcast.

Resources:

• DMEC
• From Counterculture to Clinical Treatment
• What Role Should Health Equity Have in Benefit Discussions?
• How Can Employers Prepare for Psychedelics?